Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex

References

• SchneiderHJBinding mechanisms in supramolecular complexesAngew Chem Int Ed Engl200948223924397719415701
   PubMed Web of Science ®Google Scholar
• KubikSMolecular cages and capsules with functionalized inner surfacesTop Curr Chem201231913421952842
   PubMed Web of Science ®Google Scholar
• Del ValleEMMCyclodextrins and their uses: a reviewProcess Biochem200439910331046
   Web of Science ®Google Scholar
• ZhangXWangCSupramolecular amphiphilesChem Soc Rev20114019410120890490
   PubMedGoogle Scholar
• BenitoJMGómez-GarcíaMOrtiz MelletCBaussanneIDefayeJGarcía FernándezJMOptimizing saccharide-directed molecular delivery to biological receptors: design, synthesis, and biological evaluation of glycodendrimer-cyclodextrin conjugatesJ Am Chem Soc200412633103551036315315450
   PubMedGoogle Scholar
• PaliwalSRPaliwalRPalHCEstrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxo-rubicin in breast cancer therapyMol Pharm20129117618622091702
   PubMed Web of Science ®Google Scholar
• ZhangJMaPXCyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspectiveAdv Drug Deliv Rev20136591215123323673149
   PubMed Web of Science ®Google Scholar
• DavisMEBrewsterMECyclodextrin-based pharmaceutics: past, present and futureNat Rev Drug Discov20043121023103515573101
   PubMed Web of Science ®Google Scholar
• YinJJZhouZWZhouSFCyclodextrin-based targeting strategies for tumor treatmentDrug Deliv Transl Res20133436437425788282
   PubMedGoogle Scholar
• AndréSKaltnerHFuruikeTNishimuraSIGabiusHJPersubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targetsBioconjug Chem2004151879814733587
   PubMedGoogle Scholar
• YinJJSharmaSShumyakSPSynthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatmentPloS One201385e6228923658721
   PubMed Web of Science ®Google Scholar
• DebloisGGiguèreVOestrogen-related receptors in breast cancer: control of cellular metabolism and beyondNat Rev Cancer2013131273623192231
   PubMed Web of Science ®Google Scholar
• ManavathiBDeyOGajulapalliVNBhatiaRSBugideSKumarRDerailed estrogen signaling and breast cancer: an authentic coupleEndocr Rev201334113222947396
   PubMed Web of Science ®Google Scholar
• YueWYagerJDWangJPJupeERSantenRJEstrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesisSteroids201378216117023178278
   PubMed Web of Science ®Google Scholar
• ErolesPBoschAPérez-FidalgoJALluchAMolecular biology in breast cancer: intrinsic subtypes and signaling pathwaysCancer Treat Rev201238669870722178455
   PubMed Web of Science ®Google Scholar
• LiangJShangYEstrogen and cancerAnnu Rev Physiol20137522524023043248
   PubMed Web of Science ®Google Scholar
• Dahlman-WrightKCavaillesVFuquaSAInternational Union of Pharmacology. LXIV. Estrogen receptorsPharmacol Rev200658477378117132854
   PubMed Web of Science ®Google Scholar
• KampaMPelekanouVNotasGStathopoulosENCastanasEThe estrogen receptor: two or more molecules, multiple variants, diverse localizations, signaling and functions. Are we undergoing a paradigm-shift as regards their significance in breast cancer?Hormones (Athens)2013121698523624133
   PubMedGoogle Scholar
• SoltysikKCzekajPMembrane estrogen receptors – is it an alternative way of estrogen action?J Physiol Pharmacol201364212914223756388
   PubMed Web of Science ®Google Scholar
• RenoirJMMarsaudVLazennecGEstrogen receptor signaling as a target for novel breast cancer therapeuticsBiochem Pharmacol201385444946523103568
   PubMed Web of Science ®Google Scholar
• AliSBuluwelaLCoombesRCAntiestrogens and their therapeutic applications in breast cancer and other diseasesAnnu Rev Med20116221723221054173
   PubMedGoogle Scholar
• NilssonSKoehlerKFGustafssonJADevelopment of subtype-selective oestrogen receptor-based therapeuticsNat Rev Drug Discov2011101077879221921919
   PubMed Web of Science ®Google Scholar
• GrillaudMRussierJBiancoAPolycationic adamantane-based dendrons of different generations display high cellular uptake without triggering cytotoxicityJ Am Chem Soc2014136281081924354635
   PubMedGoogle Scholar
• BohmIIsenbügelKRitterHBranscheidRKolbUCyclodextrin and adamantane host-guest interactions of modified hyperbranched poly(ethylene imine) as mimetics for biological membranesAngew Chem Int Ed Engl201150347896789921710677
   PubMedGoogle Scholar
• SilvaEKabilAKortenkampACross-talk between non-genomic and genomic signalling pathways – distinct effect profiles of environmental estrogensToxicol Appl Pharmacol2010245216017020206645
   PubMedGoogle Scholar
• MarinoMGalluzzoPAscenziPEstrogen signaling multiple pathways to impact gene transcriptionCurr Genomics20067849750818369406
   PubMed Web of Science ®Google Scholar
• ParveenSSahooSKLong circulating chitosan/PEG blended PLGA nanoparticle for tumor drug deliveryEur J Pharmacol20116702–337238321951969
   PubMed Web of Science ®Google Scholar
• TangWNgSCFacile synthesis of mono-6-amino-6-deoxy-alpha-, beta-, gamma-cyclodextrin hydrochlorides for molecular recognition, chiral separation and drug deliveryNat Protoc20083469169718388952
   PubMedGoogle Scholar
• AnandRMalangaMManetICitric acid-γ-cyclodextrin cross-linked oligomers as carriers for doxorubicin deliveryPhotochem Photobiol Sci201312101841185423900688
   PubMedGoogle Scholar
• KabouridisPSJanzenJMageeALLeySCCholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytesEur J Immunol200030395496310741414
   PubMed Web of Science ®Google Scholar
• ParkerGJLawTLLenochFJBolgerREDevelopment of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assaysJ Biomol Screen200052778810803607
   PubMedGoogle Scholar
• NilssonSMäkeläSTreuterEMechanisms of estrogen actionPhysiol Rev20018141535156511581496
   PubMed Web of Science ®Google Scholar
• ChaudhriRAOlivares-NavarreteRCuencaNHadadiABoyanBDSchwartzZMembrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36)J Biol Chem2012287107169718122247547
   PubMed Web of Science ®Google Scholar
• AlbanitoLMadeoALappanoRG protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cellsCancer Res20076741859186617308128
   PubMed Web of Science ®Google Scholar
• MelocheSPouysségurJThe ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transitionOncogene200726223227323917496918
   PubMed Web of Science ®Google Scholar
• JohnsonGLLapadatRMitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinasesScience200229856001911191212471242
   PubMed Web of Science ®Google Scholar
• DentPCrosstalk between ERK, AKT, and cell survivalCancer Biol Ther201415324524624424114
   PubMedGoogle Scholar
• FilardoEJQuinnJABlandKIFrackeltonARJrEstrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGFMol Endocrinol200014101649166011043579
   PubMed Web of Science ®Google Scholar
• BanerjeeSChamblissKLMineoCShaulPWRecent insights into non-nuclear actions of estrogen receptor-alphaSteroids201481646924252382
   PubMedGoogle Scholar
• BöttnerMThelenPJarryHEstrogen receptor-beta: tissue distribution and the still largely enigmatic physiological functionJ Steroid Biochem Mol Biol201413924525123523517
   PubMed Web of Science ®Google Scholar
• WehlingMLöselRNon-genomic steroid hormone effects: membrane or intracellular receptors?J Steroid Biochem Mol Biol20061021–518018317113980
   PubMedGoogle Scholar
• WatsonCSAlyeaRAJengYJKochukovMYNongenomic actions of low concentration estrogens and xenoestrogens on multiple tissuesMol Cell Endocrinol20072741–21717601655
   PubMed Web of Science ®Google Scholar
• DerooBJKorachKSEstrogen receptors and human diseaseJ Clin Invest2006116356157016511588
   PubMed Web of Science ®Google Scholar
• KimHYSohnJWijewickramaGTClick synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogensBioorg Med Chem201018280982120031420
   PubMedGoogle Scholar
• ClarkSRainvilleJZhaoXKatzenellenbogenBSPfaffDVasudevanNEstrogen receptor-mediated transcription involves the activation of multiple kinase pathways in neuroblastoma cellsJ Steroid Biochem Mol Biol2014139455324121066
   PubMedGoogle Scholar
• BulayevaNNGametchuBWatsonCSQuantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathwaysSteroids200469318119215072920
   PubMed Web of Science ®Google Scholar
• AdlanmeriniMSolinhacRAbotAMutation of the palmitoylation site of estrogen receptor-α in vivo reveals tissue-specific roles for membrane versus nuclear actionsProc Natl Acad Sci U S A20141112E283E29024371309
   PubMed Web of Science ®Google Scholar
• LeaWASimeonovAFluorescence polarization assays in small molecule screeningExpert Opin Drug Discov201161173222328899
   PubMed Web of Science ®Google Scholar